Signaling pathways in high-grade serous ovarian carcinoma

In collaboration with:

Poster not to be missed​ and perhaps great interest to you:

“Identification of signal transduction pathway activity with potential clinical target in high-grade serous ovarian carcinoma”.

Exhibit Halls D-H, Poster Section 24, Abstract# 4002
Wednesday, April 13, 2022 | 9:00AM – 12:30PM​

Read abstract here

​Want to learn how signal pathway activity scoring can be of benefit to you? Let us know your interest, the InnoSIGN team is more than happy to meet you in New Orleans to discuss the possibilities.

Contact us

E-Mail us
Category group 1
  • Select all
Category group 2
  • Select all